Discovering new drugs to fight TB

(Medical Xpress) -- Research at Victoria University is targeting new drugs to fight drug-resistant and other forms of tuberculosis (TB).

In June this year the first case of extensively-drug resistant TB in New Zealand was reported. The strain of Mycobacterium isolated is the most drug-resistant strain recorded to date in Australasia.

Although TB has slipped under the radar in New Zealand, around 300 new cases are diagnosed here every year. Around the world there are a massive 9.4 million new cases annually and 1.7 million people die from the disease. TB takes about the same number of lives as /—and more than malaria.

Ronan O’Toole, a senior lecturer in the School of Biological Sciences, leads a team of Victoria researchers looking for innovative new compounds to help eliminate Mycobacterium tuberculosis.

He says current clinical TB drugs have been around for more than 30 years and resistance has become a major problem.

"People with TB have to take antibiotics for six months, and that’s the short course. Some patients may not stick with the treatment to the end, and when drugs are not used appropriately, you can eventually get resistance."

In 2009, there were a quarter of a million new cases of people with multi-drug resistant tuberculosis.

Dr O’Toole recently spent time studying multi- and extensively-drug of M. tuberculosis in level 3 containment facilities at the Centre for TB Research at John Hopkins University in Baltimore.

"One of them was resistant to 10 of the available tuberculosis drugs. This leaves few drugs to treat such strains with."

With funding from the Health Research Council of New Zealand and the Wellington Medical Research Foundation, Dr O’Toole has been investigating techniques to speed up screening for to fight TB.

He and his students have developed novel procedures for identifying compounds that inhibit M. tuberculosis. These are then applied to libraries of synthetic compounds, and natural products isolated from and marine organisms, to highlight promising treatments.

"Our techniques allow us to screen thousands of compounds much faster to see where possible new treatments might come from."

Using targeted screening protocols, they can also pre-select for compounds which have a new mode of action against the cell of M. tuberculosis.

One strand of the work has seen the researchers testing native plants to see if they can help in the fight against TB. Dr O’Toole’s group has prepared extracts from a variety of New Zealand plants and found that a number of them inhibited the growth of M. tuberculosis.

The most promising extract came from the inner bark of the Pukatea tree (Laurelia novae-zelandiae). This is of interest, says Dr O’Toole, as Pukatea bark extract was reportedly used by Maori as a traditional treatment for tuberculosis ulcers. The findings indicate the potential that native plants and other organisms may have as sources of tuberculosis drugs.

In a joint project with the TB research group at the Malaghan Institute, the researchers are also trying to find out more about latent forms of the bacteria.

Dr O’Toole says the World Health Organisation has estimated that up to one-third of the world’s population carries M. tuberculosis in its latent form.

"People with latent TB are not infectious and most will not develop the symptoms of active TB but the WHO estimate highlights the extent of the reservoir that exists for the bacterium."

One goal of the project is to find out what signals drive the bacteria to enter and exit latency. A second objective is to find compounds that will kill the M. cells that are present in latent TB cases.

"Currently, we have few drugs that are effective against latent TB," says Dr O’Toole.

Despite the size of the problem, Irish-born Dr O’Toole is optimistic about the future.

"With continued investment in discovering and developing new treatments, I am confident it is a disease we will get on top of in my lifetime."

Provided by Victoria University

not rated yet
add to favorites email to friend print save as pdf

Related Stories

WHO warns of drug-resistant TB

Sep 06, 2006

The World Health Organization in Switzerland has warned of a new strain of tuberculosis that is rapidly spreading and cannot be treated with current drugs.

HIV/AIDS linked to drug resistant TB

Nov 16, 2006

U.S. scientists say a highly drug-resistant form of tuberculosis has been linked to HIV/AIDS in a study conducted in rural South Africa.

WHO: Money, drugs needed to rein in new TB strains

Mar 23, 2009

(AP) -- More money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat, the WHO announced Monday in China, where the disease has long been a leading ...

Drug-resistant tuberculosis rife in China

Dec 11, 2008

Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average. Nationwide research published in the open access journal BMC Infectious Diseases has shown that almost 10% of Chinese TB cases are re ...

Recommended for you

Ebola in mind, US colleges screen some students

9 hours ago

University students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate their campuses from the worst Ebola outbreak in ...

WHO: More Ebola cases in past week than any other

10 hours ago

The past week has seen the highest increase of Ebola cases since the outbreak in West Africa began, the World Health Organization said Friday, offering more evidence that the crisis is worsening.

User comments